Sanofi says to reach settlement on Zantac lawsuits in US
French pharmaceutical giant Sanofi said Thursday it had reached a preliminary agreement on settling thousands of US lawsuits concerning its heartburn drug Zantac.
Apr 4, 2024
0
47
Heterocyclic Compounds: News and Research on Furans
MeSH tree: D03.383.312
UTI drug gepotidacin performs well in clinical trials compared to nitrofurantoin
A team of medical researchers with affiliations to British multinational pharmaceutical and biotechnology company GlaxoSmithKline (GSK) has found that a new antibiotic drug the company developed to treat urinary tract infections ...
Ranitidine study finds no elevated risk of cancer... despite finding elevated cancer rates
Research led by Seng Chan You, MD, at the Yonsei University College of Medicine, Korea, has investigated the risk of cancer associated with use of the drug ranitidine compared to other histamine-2 receptor antagonists (H2RAs) ...
Drugmaker settles US Zantac cancer case
British pharmaceutical group GlaxoSmithKline said Friday it has settled a US lawsuit which had alleged heartburn drug Zantac caused cancer, but admitted no liability.
Jun 23, 2023
0
58
Drugmaker shares rally on US cancer ruling over Zantac
Shares in British pharmaceutical group GlaxoSmithKline and French peer Sanofi jumped Wednesday after a US court dismissed claims that heartburn drug Zantac caused cancer.
Dec 7, 2022
0
41
New type of antibiotic could fight tough-to-treat UTIs
The world desperately needs new antibiotics to fight infection as bacteria become resistant to existing options.
Nov 4, 2022
0
148
